Literature DB >> 23670276

Salt-inducible kinase 1 is involved in high glucose-induced mesangial cell proliferation mediated by the ALK5 signaling pathway.

Jie Yu1, Xiaopeng Hu, Zhengdong Yang, Hiroshi Takemori, Yanhong Li, Huan Zheng, Shicong Hong, Qiuhong Liao, Xiuying Wen.   

Abstract

High glucose levels can induce mesangial cell proliferation and extracellular matrix (ECM) accumulation through the type I activin receptor-like kinase 5 (ALK5) signaling pathway. Salt-inducible kinase 1 (SIK1) prevents fibrosis by downregulating ALK5, while the expression level of the SIK1 protein itself is downregulated by glucose in neuronal cells following ischemia. In this study, we investigated the correlation between SIK1 and the ALK5 signaling pathway in a rat glomerular mesangial cell line (HBZY-1 cells). We found that high glucose levels downregulated the expression level of SIK1 and suppressed the phosphorylation of SIK1 at Thr-182. The downregulation of SIK1 by high glucose was accompanied by the activation of the ALK5 signaling pathway, while the overexpression of SIK1 in the HBZY-1 cells resulted in a decrease in the ALK5 protein level, as well in the levels of its downstream targets, including fibronectin and plasminogen activator inhibitor type I. In conclusion, high glucose may activate the ALK5 signaling pathway by downregulating SIK1, and SIK1 may be a protective factor against cellular proliferation and ECM accumulation in glomerular mesangial cells under high glucose conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670276     DOI: 10.3892/ijmm.2013.1377

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.

Authors:  Zhe Zhang; Zhiyong Luo; Wenpu Min; Lin Zhang; Yaqun Wu; Xiaopeng Hu
Journal:  Oncotarget       Date:  2017-06-27

2.  The protein kinase SIK downregulates the polarity protein Par3.

Authors:  Michael Vanlandewijck; Mahsa Shahidi Dadras; Marta Lomnytska; Tanzila Mahzabin; Martin Lee Miller; Christer Busch; Søren Brunak; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Oncotarget       Date:  2017-12-31

3.  Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.

Authors:  DaoFei Song; Lei Yin; Chang Wang; XiuYing Wen
Journal:  PLoS One       Date:  2019-06-24       Impact factor: 3.240

4.  Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus.

Authors:  Rachael D Wright; Paraskevi Dimou; Sarah J Northey; Michael W Beresford
Journal:  J Inflamm (Lond)       Date:  2019-11-14       Impact factor: 4.981

5.  Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats.

Authors:  Daofei Song; Lei Yin; Chang Wang; Xiuying Wen
Journal:  BMC Complement Med Ther       Date:  2020-01-31

6.  Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.

Authors:  Jinxiu Hu; Jiao Qiao; Qun Yu; Bing Liu; Junhui Zhen; Yue Liu; Qiqi Ma; Yanmei Li; Qianhui Wang; Cheng Wang; Zhimei Lv
Journal:  J Transl Med       Date:  2021-02-15       Impact factor: 5.531

7.  SIK1 Regulates CRTC2-Mediated Gluconeogenesis Signaling Pathway in Human and Mouse Liver Cells.

Authors:  Chang Wang; Daofei Song; Jiahui Fu; Xiuying Wen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555

Review 8.  The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.

Authors:  Zicheng Sun; Qiwei Jiang; Jie Li; Jianping Guo
Journal:  Signal Transduct Target Ther       Date:  2020-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.